Titan Biotech Limited

TITANBIO6

INE150C01011

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 06:00:56 2024-07-16 am EDT			5-day change	1st Jan Change
604 ^INR	+0.25%		+0.80%	+47.47%

May. 29	Titan Biotech Limited Recommends Dividend for the Financial Year Ended on 31 March, 2024	CI
May. 29	Titan Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Titan Biotech Limited Recommends Dividend for the Financial Year Ended on 31 March, 2024

May 29, 2024 at 06:23 am EDT

Titan Biotech Limited have recommended a dividend of INR 2.00/- per equity share for the Financial Year ended on 31st March, 2024. The said dividend, if declared at the upcoming Annual General Meeting, will be credited/dispatched to the eligible shareholders after the AGM within the limit as prescribed under the Companies Act, 2013 and other applicable laws.

Latest news about Titan Biotech Limited

Titan Biotech Limited Recommends Dividend for the Financial Year Ended on 31 March, 2024	May. 29	CI
Titan Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 29	CI
Titan Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 29	CI
Titan Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Titan Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Titan Biotech Limited Approves Board Appointments, Effective October 1, 2023	23-09-30	CI
Titan Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-05	CI
Titan Biotech Limited Announces Resignation of Rekha Dalmia as Non-Executive Independent Director	23-07-26	CI
Titan Biotech Limited Recommends Dividend for the Financial Year Ended on March 31, 2023	23-05-30	CI
Titan Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-04	CI
Titan Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Indian Indices Extend Loss on Thursday; Tech Mahindra Tops Laggards	22-11-03	MT
Indian Indices Post Marginal Loss; Titan Jumps 5%	22-10-07	MT
Titan Logs 18% Jump in Fiscal Q2 Overall Sales	22-10-06	MT
Titan Biotech Limited Appoints Raja Singla as Executive Director, with Effect from October 1, 2022	22-10-01	CI
Titan Biotech Limited Appoints Mr. Raja Singla as Whole Time Director	22-10-01	CI
Titan Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-08-31	CI
Titan Biotech Limited Recommends Dividend for the Financial Year Ended on 31 March, 2022	22-05-30	CI
Titan Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Titan Biotech Limited Recommends Dividend for the Financial Year 2021	21-08-25	CI
Titan Biotech Limited Announces Resignation of Mr. Jai Parkash Bansal as Director	21-08-10	CI
Titan Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-10	CI
Titan Biotech Limited Recommends Dividend for the Financial Year Ended on March 31, 2021	21-06-29	CI
Titan Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-29	CI
Titan Biotech Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-01-27	CI

Chart Titan Biotech Limited

Duration

Period

More charts

Company Profile

Titan Biotech Limited is an India-based company primarily engaged in the business of biological products. The Company is a manufacturer and exporter of the biological products used in the field of pharmaceuticals, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, microbiology, and others. The Company manufactures peptones, biological extracts, culture media and chemicals. It offers its products under various categories, such as Food Ingredients, Collagen and Proteins, Pharmaceuticals and Nutraceuticals, Animal Nutrition, Probiotics and Fermentation Ingredients, Agriculture Products, Culture Media and Natures Island. Its Food Ingredients include hydrolyzed vegetable protein (HVP), yeast extract powder, calcium propionate powder, potassium sorbate and calcium lactate. Its Collagen and Proteins include soya protein isolate, collagen peptides, chicken protein isolate, brown rice protein, and others.

Sector

Pharmaceuticals

Calendar

2024-08-06 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TITAN BIOTECH LIMITED	+47.47%	59.74M
ELI LILLY AND COMPANY	+61.53%	848B
NOVO NORDISK A/S	+38.95%	627B
JOHNSON & JOHNSON	-3.66%	363B
MERCK & CO., INC.	+15.06%	318B
ABBVIE INC.	+9.18%	299B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	225B
AMGEN INC.	+15.67%	179B
PFIZER, INC.	+2.47%	167B